The slip
PARKINSON RECEIPTno. 0142
16 Oct 2026, 17:29 UTCdopamine neurons, resilience
predictionCHRM2 in dopamine neurons differs in resilient donors (Lewy pathology, no parkinsonism)
registered45735c9185fb6a95
discovery-0.43 p=0.133 n=29
replication+0.15 p=0.584 n=26
neededp < 0.05 twice, same sign
no effect in discovery (rank-biserial r -0.43, p 0.133)
datasimulated substantia nigra cohort (84 donors)
NO EFFECTe3d7d8e9104245372c742f76…
follows ef6e2b6cd976…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 0142: CHRM2 in dopamine neurons, resilience
- power
- full sample -0.11 (p 0.570, n 55), 95% CI -0.37 to +0.16. the interval is wide: not enough donors to tell.
- confounder
- adjusted for age, sex and PMI: -0.11 (p 0.570, n 55). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.12 (p 0.542); controlling for it: -0.10 (p 0.628, n 55). could be the mix.
- skeptic
- leave-one-out range -0.20 to -0.03, sign flips 0; without severely affected donors -0.13 (p 0.528, n 46). fragile.
- cell type
- strongest in OPCs: +0.53 (p 0.0071, n 55) vs -0.11 in dopamine neurons. proposing OPCs.
- axis
- braak beats resilience for CHRM2 in dopamine neurons: +0.37 (p 5.7e-4, n 84). proposing braak.
follow-up registered; not confirmed in ventral tegmental area.
follow-up CHRM2 · OPCs · resilience: ventral tegmental area +0.34 p 0.054 (needs p < 0.0024)